SMARTDIAB: A Communication and Information Technology Approach for the Intelligent Monitoring, Management and Follow-up of Type 1 Diabetes Patients

被引:50
|
作者
Mougiakakou, Stavroula G. [1 ]
Bartsocas, Christos S. [2 ,3 ]
Bozas, Evangelos [4 ]
Chaniotakis, Nikos [5 ]
Iliopoulou, Dimitra [6 ]
Kouris, Ioannis [6 ]
Pavlopoulos, Sotiris [1 ]
Prountzou, Aikaterini [6 ]
Skevofilakas, Marios [6 ]
Tsoukalis, Alexandre [7 ]
Varotsis, Kostas [5 ]
Vazeou, Andrianni [8 ]
Zarkogianni, Konstantia [6 ]
Nikita, Konstantina S. [6 ]
机构
[1] Natl Tech Univ Athens, Inst Commun & Comp Syst, Athens 15780, Greece
[2] MITERA Gen Matern, Maroussi 15123, Greece
[3] Childrens Hosp, Maroussi 15123, Greece
[4] Natl & Kapodistrian Univ Athens, Fac Nursing, Sch Hlth Sci, Athens 11527, Greece
[5] Univ Crete, Dept Chem, Iraklion 71409, Greece
[6] Natl Tech Univ Athens, Sch Elect & Comp Engn, Athens 15780, Greece
[7] Micrel Med Devices, Pallini 15351, Greece
[8] PA Kyriakou Childrens Hosp, Dept Pediat, Ctr Diabet, Athens 11527, Greece
关键词
Closed-loop glucose control; diabetes management; home care; information and communication technologies; telemedicine; PREDICTIVE CONTROL; GLUCOSE; INSULIN; SIMULATION; MODEL; TELEMEDICINE; MELLITUS; SYSTEM;
D O I
10.1109/TITB.2009.2039711
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
SMARTDIAB is a platform designed to support the monitoring, management, and treatment of patients with type 1 diabetes mellitus (T1DM), by combining state-of-the-art approaches in the fields of database (DB) technologies, communications, simulation algorithms, and data mining. SMARTDIAB consists mainly of two units: 1) the patient unit (PU); and 2) the patient management unit (PMU), which communicate with each other for data exchange. The PMU can be accessed by the PU through the internet using devices, such as PCs/laptops with direct internet access or mobile phones via a Wi-Fi/General Packet Radio Service access network. The PU consists of an insulin pump for subcutaneous insulin infusion to the patient and a continuous glucose measurement system. The aforementioned devices running a user-friendly application gather patient's related information and transmit it to the PMU. The PMU consists of a diabetes data management system (DDMS), a decision support system (DSS) that provides risk assessment for long-term diabetes complications, and an insulin infusion advisory system (IIAS), which reside on a Web server. The DDMS can be accessed from both medical personnel and patients, with appropriate security access rights and front-end interfaces. The DDMS, apart from being used for data storage/retrieval, provides also advanced tools for the intelligent processing of the patient's data, supporting the physician in decision making, regarding the patient's treatment. The IIAS is used to close the loop between the insulin pump and the continuous glucose monitoring system, by providing the pump with the appropriate insulin infusion rate in order to keep the patient's glucose levels within predefined limits. The pilot version of the SMARTDIAB has already been implemented, while the platform's evaluation in clinical environment is being in progress.
引用
收藏
页码:622 / 633
页数:12
相关论文
共 50 条
  • [1] A communication and information technology infrastructure for real time monitoring and management of type 1 diabetes patients
    Skevofilakas, Marios
    Mougiakakou, Stavroula G.
    Zarkogianni, Konstantia
    Aslanoglou, Erika
    Pavlopoulos, Sotiris A.
    Vazeou, Andriani
    Bartsocas, Christos S.
    Nikita, Konstantina S.
    [J]. 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-16, 2007, : 3685 - 3688
  • [2] Information and communication technologies for the follow-up of patients
    Baca-Garcia, E.
    [J]. EUROPEAN PSYCHIATRY, 2016, 33 : S49 - S49
  • [3] Intensive diabetes management in adolescents with type 1 diabetes: The importance of intensive follow-up
    Lawson, ML
    Frank, MR
    Fry, MK
    Perlman, K
    Sochett, EB
    Daneman, D
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2000, 13 (01): : 79 - 84
  • [4] Follow-up of kidney biopsies in normoalbuminuric patients with type 1 diabetes
    Perrin, NESS
    Torbjörnsdotter, TB
    Jaremko, GA
    Berg, UB
    [J]. PEDIATRIC NEPHROLOGY, 2004, 19 (09) : 1004 - 1013
  • [5] Follow-up of kidney biopsies in normoalbuminuric patients with type 1 diabetes
    Nina Elisabeth Staffansdotter Sohlman Perrin
    Torun Birgitta Torbjörnsdotter
    Georg Alexander Jaremko
    Ulla Birgitta Berg
    [J]. Pediatric Nephrology, 2004, 19 : 1004 - 1013
  • [6] One year follow-up of patients with type II diabetes after implementation of staged diabetes management
    Mazze, R
    Burman, R
    Castle, G
    Sundem, S
    Simonson, G
    Strock, E
    Bradley, R
    Peterson, K
    [J]. DIABETOLOGIA, 1997, 40 : 2610 - 2610
  • [7] Follow-up of type 2 diabetes patients (excluding complications)
    Charbonnel, B
    Aptel, I
    Amouyel, P
    Attali, JR
    Aulanier, S
    Balarac, N
    Bukowski, JV
    Cathelineau, B
    de Broucker, T
    Denis, C
    Mausset, J
    Ormières, JJ
    Passa, P
    Paulhan, A
    Pousset, F
    Pouteil-Noble, C
    Laversin, S
    Anouchian, P
    Aquino, JP
    Aubert, JP
    Baufine-Ducrocq, H
    Bernard, MH
    Bonnet, A
    Chabassol, E
    Cirioni, A
    Colas, C
    Cordonnier, D
    Coscas, G
    Cuvelier, D
    Dany, F
    Derrien, G
    Desrousseaux, B
    Dueymes, JM
    Dupasquier, JP
    Dussart, L
    Gemez-Lestradet, C
    Gerson, M
    Grimaldi, A
    Gros, M
    Guerot, C
    Guyot-Argenton, C
    Halimi, S
    Kourilsky, O
    Lanéelle, D
    Laudet, J
    Lelong, S
    Malinsky, M
    Meffre, C
    Moulin, P
    Olaya, E
    [J]. PRESSE MEDICALE, 1999, 28 (19): : 1023 - 1027
  • [8] Telemedicine Influence on the Follow-Up of Type 2 Diabetes Patients
    Rodriguez-Idigoras, Maria I.
    Sepulveda-Munoz, Jesus
    Sanchez-Garrido-Escudero, Ramon
    Martinez-Gonzalez, Jose L.
    Escolar-Castello, Jose L.
    Paniagua-Gomez, Isabel M.
    Bernal-Lopez, Rosa
    Fuentes-Simon, Maria V.
    Garofano-Serrano, Daniel
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (07) : 431 - 437
  • [9] Celiac disease in type 1 diabetes: Screening and follow-up
    Rewers, M
    Klingensmith, GA
    Redondo, M
    Simmons, J
    Norris, J
    Eisen-Barth, G
    Hoffenberg, EJ
    [J]. DIABETES, 2004, 53 : A424 - A424
  • [10] Type 1 diabetes mellitus and asthma: A follow-up study
    d'Annunzio, G.
    Tosca, M. A.
    Pistorio, A.
    Silvestri, M.
    Romanisio, G.
    Lorini, R.
    Rossi, G. A.
    Ciprandi, G.
    [J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2015, 43 (02) : 225 - 227